Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H27FN4O2 |
| Molecular Weight | 397.4763 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)CC1=C2N=C(C)C=C(C)N2N=C1C3=CC=C(OCC[18F])C=C3
InChI
InChIKey=FLZZFWBNYJNHMY-VNRZBHCFSA-N
InChI=1S/C22H27FN4O2/c1-5-26(6-2)20(28)14-19-21(17-7-9-18(10-8-17)29-12-11-23)25-27-16(4)13-15(3)24-22(19)27/h7-10,13H,5-6,11-12,14H2,1-4H3/i23-1
| Molecular Formula | C22H27FN4O2 |
| Molecular Weight | 397.4763 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
BAY85-8102 (widely known as (18)F-DPA-714) is a specific radioligand for the translocator protein (TSPO). TSPO, formerly known as the peripheral benzodiazepine receptor, is dramatically upregulated under pathologic conditions. BAY85-8102 in combination with positron emission tomography imaging participated in phase I clinical trials for investigation of neuroinflammation in Alzheimer's patients. However, this study was terminated early. Clinical pharmacology/efficacy parameters planned in the protocol were not evaluated at the end of the study
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO). | 2010-10-01 |
|
| DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. | 2008-05 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01009359
Alzheimer Disease patients: Single intervenous bolus injection of 250 MBq BAY85-8102 on day one of the treatment period, PET/CT
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:08:25 GMT 2025
by
admin
on
Mon Mar 31 23:08:25 GMT 2025
|
| Record UNII |
0VMV8Z3972
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23582365
Created by
admin on Mon Mar 31 23:08:25 GMT 2025 , Edited by admin on Mon Mar 31 23:08:25 GMT 2025
|
PRIMARY | |||
|
0VMV8Z3972
Created by
admin on Mon Mar 31 23:08:25 GMT 2025 , Edited by admin on Mon Mar 31 23:08:25 GMT 2025
|
PRIMARY | |||
|
958233-09-5
Created by
admin on Mon Mar 31 23:08:25 GMT 2025 , Edited by admin on Mon Mar 31 23:08:25 GMT 2025
|
PRIMARY | |||
|
300000042435
Created by
admin on Mon Mar 31 23:08:25 GMT 2025 , Edited by admin on Mon Mar 31 23:08:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET->RADIOLIGAND | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Substance Name: 18F-DPA-714, RN: 958233-09-5; Registry Numbers: (1)CAS Registry Number: 958233-09-5, (2)System Generated Number: 0958233095
|